JV of Alembic receives approval for Lidocaine Ointment JV of Alembic receives approval for Lidocaine Ointment Shohini Nath / Monday, November 26, 2018 / Article rating: 5.0 Alembic Pharma’s joint venture, Aleor Dermaceuticals has received USFDA approval for Lidocaine Ointment USP. Shares of the company were up by almost 2 per cent intraday.
SJVN receives repeat order in Satluj basin SJVN receives repeat order in Satluj basin Gayathri Udyawar / Monday, November 26, 2018 / Article rating: 5.0 The company has received a fresh order from the state government of Himachal Pradesh allotting the Jangi-Thopan-Powari (780 MW) project on BOOT basis.
Godrej Properties partners with Hero Cycles Godrej Properties partners with Hero Cycles Apurva Joshi / Monday, November 26, 2018 / Article rating: 5.0 Godrej Fund Management and Godrej Properties have entered into a joint venture agreement with Hero Cycles to develop a prime office development on Golf Course Road, Gurgaon. Godrej Fund Management is the real estate private equity arm of the Godrej Group, and Godrej Properties Limited is one of India's leading real estate developers.
Lupin receives USFDA approval for two drugs Lupin receives USFDA approval for two drugs Dnyanada Kulkarni / Monday, November 26, 2018 / Article rating: 5.0 Pharma major Lupin received approval from the USFDA for two important drugs namely - Clomipramine Hydrochloride Capsules and Potassium Chloride for oral solution USP.
SPARC soars 8 per cent on the back of successful research data SPARC soars 8 per cent on the back of successful research data Dnyanada Kulkarni / Monday, November 26, 2018 / Article rating: 5.0 The shares of Sun Pharma Advanced Research Company (SPARC) gained 8 per cent in Monday's morning session as the company announced the positive results of its pivotal bioequivalence study for a cancer drug.
Are solution-based mutual funds good? Are solution-based mutual funds good? Henil Shah / Monday, November 26, 2018 / Article rating: 5.0 SEBI, in mutual funds categorization, has created a separate category for mutual funds which are specifically dedicated to an individual’s financial goals such as child education and retirement. These MFs are known as solution-based mutual funds. But is it worth investing in them? Let’s find out.
Ten stocks close to their 52-week low Ten stocks close to their 52-week low Shital Jibhe / Monday, November 26, 2018 / Article rating: 3.5 Following stocks are close to their 52-week low as at 12.49 p.m. on November 26, 2018.
Ten stocks close to their 52-week high Ten stocks close to their 52-week high Shital Jibhe / Monday, November 26, 2018 / Article rating: 4.0 The markets on November 26, 2018 opened up. BSE Sensex is trading at 35,059.57, up by 78.55 points and the Nifty is trading at 10,538.95, up by 12.20 points.
BEML receives order worth Rs. 3,015 crore, stock surges BEML receives order worth Rs. 3,015 crore, stock surges Amir Shaikh / Monday, November 26, 2018 / Article rating: 5.0 BEML a miniratna company which manufactures rail coaches and spares, and mining equipment has bagged order DMRC for the supply of 378 metro coaches (63 metro trains) to Mumbai Metro Line - 2 and 7 projects.
Glenmark bags tentative USFDA approval for Clobetasol Propionate Foam Glenmark bags tentative USFDA approval for Clobetasol Propionate Foam Shohini Nath / Monday, November 26, 2018 / Article rating: 5.0 Glenmark has received tentative approval for Colobetasol Propionate Foam from the USFDA. The shares of the company were trading on the positive side in the early trading hours of Monday.